A multimodal conversational agent for DNA, RNA and protein tasks
Bernardo P. de Almeida(Research Institute of Molecular Pathology), Thomas Pierrot(Institute on Taxation and Economic Policy), Christopher Blum(BioNTech (Germany)), Lorenz Hexemer(BioNTech (Germany)), Chandana Rajesh(New York State Department of State), Stefan Laurent(BioNTech (Germany)), Karim Beguir, Alexandre Laterre, Uğur Şahin(University Medical Center of the Johannes Gutenberg University Mainz), Priyanka Pandey(BioNTech (Germany)), Hugo Dalla-Torre, Marie Lopez(Institute on Taxation and Economic Policy), Guillaume Richard, Maren Lang(BioNTech (Germany))
Cited by 21
Related Papers
mRNA-based therapeutics — developing a new class of drugs
|Nature Reviews Drug Discovery|2014|2.4k
BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans
|Nature|2021|828
BNT162b vaccines protect rhesus macaques from SARS-CoV-2
|Nature|2021|735